REQUEST A DEMO
Total
USD $0.00
Search more companies

Ftf Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ftf Pharma Private Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ftf Pharma Private Limited is an unlisted company, incorporated on 20/06/2012. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2012PTC070818 and registration number is 070818. The company is a professional, scientific and technical company, it is engaged in other professional, scientific and technical activities.

Legal Address
Bl.No.193(P)211(P),Xcelon Ind. Park,Chak De India Weigh Bridge Rd,Vasana,Chacharwadi, Ta-Sanand
Ahmedabad; Gujarat; Postal Code: 382213

Contact Details: Purchase the Ftf Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Ftf Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Ftf Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Ftf Pharma Private Limited report to view the information.
Incorporation Date:
June 20, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after Ftf Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.29%
Total operating revenue
19.35%
Operating profit (EBIT)
1153.42%
EBITDA
230.6%
Net Profit (Loss) for the Period
962.45%
Total assets
-2.63%
Total equity
15.4%
Operating Profit Margin (ROS)
17.45%
Net Profit Margin
11.98%
Return on Equity (ROE)
11.74%
Debt to Equity Ratio
-30.24%
Quick Ratio
0.18%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?